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Dear Editor,
we have read with attention the article by Zayni et al.1
comparing the effect of 1 or 2 weekly PRP injection(s)
whose conclusions are opposed to the findings of our
previously published study2. Indeed, they observed that
2 injections lead to better results than only 1, but our
data suggested that a single injection is sufficient to ob-
tain the same results. The populations in the 2 studies
seem to be not exactly similar at baseline, but perhaps
the number of injections should be tailored to severity.
However this statement must still to be demonstrated.
Beside the number of injections, other differences are
observed in the experimental protocol. Zayni et al. used
the ACP system which expect to produce a PRP with
platelet concentration twice as high as in whole blood
and without leukocytes. The PRP in our study was ob-
tained using an apheresis machine capable of extracting
a reproducible platelet concentration of 850,000
units/microlitre (+/- 4 times as high as whole blood) and
without white or red cells. The number of platelets obtai-
ned in the injected PRP is very important. Indeed, plate-
let secretome is composed of hundreds of molecules,
and on the basis of α granule content, PRP platelets
contain proteins with opposing activities: coagulation
factors and anticoagulants; proteins that encourage and
those that discourage angiogenesis; and proteases and
their inhibitors. Thus to standardize and to understand
the efficacy of the PRP3, it could be helpful to have
exactly the same platelet concentration, as obtained with
the aphaeresis machine, but not with the ACP system.
The injection method (under ultrasound guidance) was
comparable in both studies but the platelet activation by
CaCl2, to activate the platelets, leading to their degra-
nulation, was triggered only in ours.
Despite both studies prescribed an eccentric rehabilita-
tion protocol4, the starting points differed: Zayni et al.
recommended to wait a period of 2 weeks while we
started it as soon as the painful period was finished. Fi-
nally, the best obtained results were similar in the 2 re-
ports, with a 2 years follow-up in the Zayni et al. series
and 1 year in our study.
Zayni et al. protocol was based on the preclinical re-
search by Parafioriti et al.5 who observed in the rat
model that a single PRP injection in Achilles tendon
tear had a limited effectiveness and its effect dissipates
after one week. However, our preclinical study on rats
showed that PRP injection not only leads to a better
early enhancement of the healing process but also to a
better tendon structure up to 1 month after injection6.
From this comparison, it seems that the key factor to a
successful healing is the platelets concentration. In-
deed, since our best results are comparable to Zayni’s,
a platelet concentration 4 times as high as whole blood
is needed, either in one or multiple injections. The
apheresis machine also enables the reproducibility of
the PRP preparation7, producing every time the same
platelet concentration, whatever the patient whole
blood initial concentration. This is not true for the ACP
system, for which the platelet concentration varies with
respect to its natural concentration in the patients’
whole blood, as demonstrated by the analysis of similar
PRP preparation techniques8,9. Furthermore, the multi-
plication of injections increases the risk of complica-
tions, the treatment price and the patient discomfort,
having to go multiple times to the doctor or hospital10.
In conclusion, the number of injections of PRP needed
to obtain good clinical results can vary depending of the
quality of the PRP used or, perhaps, of the severity of
the tendinopathy. Further well-standardized studies re-
main necessary, according to the recommendations of
the Journal11.
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